Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 755 | 1,868 | 1,317 | 4,783 | 843 |
| Marketable Securities | 1,780 | 1,772 | 2,769 | N/A | N/A |
| Receivables | 620 | 617 | 742 | 449 | 421 |
| TOTAL | $3,290 | $4,300 | $4,874 | $5,285 | $1,401 |
| Non-Current Assets | |||||
| PPE Net | 263 | 234 | 247 | 273 | 298 |
| Other Non-Current Assets | 241 | 218 | 17 | 163 | 151 |
| TOTAL | $504 | $452 | $264 | $436 | $449 |
| Total Assets | $3,794 | $4,752 | $5,138 | $5,721 | $1,850 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 594 | 405 | 551 | 267 | 660 |
| Accrued Expenses | 606 | 656 | 605 | 831 | 790 |
| TOTAL | $1,200 | $1,061 | $1,156 | $1,098 | $1,450 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 239 | 210 | 0 | 164 | 147 |
| TOTAL | $239 | $210 | $N/A | $164 | $147 |
| Total Liabilities | $1,439 | $1,271 | $1,156 | $1,262 | $1,597 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 679 | 679 | 673 | 668 | 660 |
| Common Shares | 7 | 7 | 7 | 7 | 6 |
| Retained earnings | -50,108 | -48,590 | -47,508 | -46,929 | -45,780 |
| TOTAL | $2,355 | $3,481 | $3,982 | $4,459 | $253 |
| Total Liabilities And Equity | $3,794 | $4,752 | $5,138 | $5,721 | $1,850 |